Nurse Practitioner, Adult Health · Freehold, NJ
NPI
1376607861
Since 2006
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
901 W Main St
Freehold, NJ, 07728
Phone (732) 294-2505
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
219 services
Medicare patients, 2024
104
Average age 61
Drug cost, 2024
$4.0M
2,126 prescriptions
Company payments, 2025
$19K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dana J Beenstock was code 99214 (office e&m - established), 98 times for 69 patients. In total Dana J Beenstock billed 219 services in 7 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 98 | 69 | $58.86 | $5,768 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 38 | 30 | $10.63 | $404 |
| 99215 Office E&M - Established | Facility | 23 | 20 | $99.01 | $2,277 |
| 99213 Office E&M - Established | Facility | 15 | 14 | $42.73 | $641 |
| 99213 Office E&M - Established | Office | 12 | 11 | $61.74 | $741 |
By year: 2022 $18K for 296 services; 2023 $15K for 264 services; 2024 $11K for 219 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dana J Beenstock prescribed most often to Medicare patients was Baclofen, with 298 prescriptions and refills. In total Dana J Beenstock wrote 2,126 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 298 | 636 | 113 | $7,066 |
| Gabapentin Generic | 182 | 391 | 66 | $4,542 |
| Dalfampridine Er Dalfampridine | 127 | 217 | 31 | $79K |
| Modafinil Generic | 89 | 104 | 31 | $7,073 |
| Mayzent Siponimod | 80 | 98 | 15 | $935K |
| Alprazolam Generic | 76 | 76 | 26 | $589 |
| Tizanidine Hcl Generic | 71 | 154 | 21 | $1,876 |
| Pregabalin Generic | 59 | 96 | 15 | $1,223 |
| Vumerity Diroximel Fumarate | 48 | 60 | Under 11 | $536K |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 46 | 46 | Under 11 | $1,148 |
| Zeposia Ozanimod Hydrochloride | 43 | 55 | Under 11 | $474K |
| Diazepam Generic | 41 | 41 | 14 | $146 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 41 | 41 | 11 | $2,218 |
| Aubagio Teriflunomide | 40 | 54 | Under 11 | $493K |
| Escitalopram Oxalate Generic | 40 | 116 | 18 | $469 |
Brand drugs: 416 claims; generic drugs: 1,710 claims; opioid claims: 82.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dana J Beenstock $19K ($19K in general payments such as food, travel and fees) from 18 companies. The largest payer was TG Therapeutics, Inc. with $13K.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 31 | $13K |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $3,234 |
| Biogen, Inc. BIIB | 28 | $635 |
| EMD Serono, Inc. MRK.DE | 18 | $396 |
| Novartis Pharmaceuticals Corporation NVS | 32 | $328 |
| Abbvie Inc. ABBV | 24 | $301 |
| Amgen Inc. AMGN | 5 | $293 |
| Genentech USA, Inc. ROG.SW | 9 | $150 |
| Vanda Pharmaceuticals Inc. VNDA | 12 | $148 |
| Celgene Corporation BMY | 7 | $148 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.